The absorption site of cyclosporin in the human gastrointestinal tract.

1. An emulsion preparation of cyclosporin was administered locally to different parts of the small and large intestine by gavage: to the duodenum (opposite to the papilla of Vater), jejunum (150 cm distal to the teeth), ileum (300 cm distal to the teeth), and to the colon descendens (30 cm proximal to the anus). 2. The bioavailability of cyclosporin after these instillations was compared with that after oral administration of a hard gelatine capsule formulation. 3. Cyclosporin was found to be absorbed predominantly in the small intestine. This may have implications for dosage in patients with reduced absorptive surface area.

[1]  J. Emond,et al.  Small-bowel length and the dose of cyclosporine in children after liver transplantation. , 1990, The New England journal of medicine.

[2]  G. Fritzsch,et al.  Cyclosporin binding to a protein component of the renal Na(+)-D-glucose cotransporter. , 1990, The Journal of biological chemistry.

[3]  S N Rasmussen,et al.  A placebo-controlled, double-blind, randomized trial of cyclosporine therapy in active chronic Crohn's disease. , 1989, The New England journal of medicine.

[4]  V. Binder,et al.  TREATMENT OF REFRACTORY ULCERATIVE COLITIS WITH CYCLOSPORIN ENEMAS , 1989, The Lancet.

[5]  N. Stacey,et al.  Inhibition of taurocholate transport by cyclosporin A in cultured rat hepatocytes. , 1988, The Journal of pharmacology and experimental therapeutics.

[6]  D. V. van Thiel,et al.  Effect of bile on cyclosporin absorption in liver transplant patients. , 1988, British journal of clinical pharmacology.

[7]  W. Pardridge,et al.  Influence of blood components on the tissue uptake indices of cyclosporin in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[8]  J. Rosenthaler,et al.  Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood. , 1988, Clinical chemistry.

[9]  F. Horber,et al.  Trough levels and concentration time curves of cyclosporine in patients undergoing renal transplantation , 1988, Clinical pharmacology and therapeutics.

[10]  W. Hendrickse,et al.  Pediatric liver transplantation: the Dallas experience. , 1987, Transplantation proceedings.

[11]  G. Williams,et al.  MALABSORPTION OF CYCLOSPORIN IN RENAL TRANSPLANT RECIPIENT WITH CROHN'S DISEASE , 1987, The Lancet.

[12]  R. Sawchuk,et al.  Absorption of cyclosporine from rabbit small intestine in situ. , 1986, Journal of pharmaceutical sciences.

[13]  P. Rosoff,et al.  Cyclosporine A inhibits Ca2+-dependent stimulation of the Na+/H+ antiport in human T cells , 1986, The Journal of cell biology.

[14]  L. Mátyus,et al.  Cyclosporin A depolarizes cytoplasmic membrane potential and interacts with Ca2+ ionophores. , 1986, Biochimica et biophysica acta.

[15]  D. Holt,et al.  The effect of vehicle on the oral absorption of cyclosporin. , 1986, British journal of clinical pharmacology.

[16]  R. Venkataramanan,et al.  Clinical Pharmacokinetics of Cyclosporin , 1986, Clinical pharmacokinetics.

[17]  D. S. Gordon,et al.  Cyclosporine , 1986, Transplantation proceedings.

[18]  W. Cefalu,et al.  Restrictive Transport of a Lipid‐Soluble Peptide (Cyclosporin) Through the Blood–Brain Barrier , 1985, Journal of neurochemistry.

[19]  R. Venkataramanan,et al.  Pharmacokinetics and Monitoring of Cyclosporine Following Orthotopic Liver Transplantation , 1985, Seminars in liver disease.

[20]  R. Venkataramanan,et al.  The effect of food on cyclosporine absorption. , 1985, Transplantation.

[21]  J. Biggs,et al.  Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction , 1984, British journal of haematology.

[22]  A. Laupacis,et al.  The effects and side effects of cyclosporine: relationship to drug pharmacokinetics. , 1982, Transplantation proceedings.

[23]  R. Iman,et al.  Rank Transformations as a Bridge between Parametric and Nonparametric Statistics , 1981 .

[24]  B. Kahan.  Drug therapy: cyclosporine , 1989 .